Government
Budget funding to avert massive childcare worker exodus
The Albanese government is preparing a multibillion-dollar budget package to prevent a "wage cliff" for 60,000 childcare workers.
Mahathir Bayena
Crypto JournalistCrypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
Contact
Contact editorial teamArticles by Mahathir Bayena
Health
OKYO Pharma reports quality-of-life breakthrough for urcosimod in nerve pain trial
KYO Pharma (NASDAQ:OKYO) reported new exploratory Phase 2a findings for its lead candidate, urcosimod (0.05%), demonstrating that the topical therapy significantly improves the quality of life (QoL) for patients suffering from neuropathic corneal pain (NCP).
Technology
Weibo surpasses $1.7B in annual revenue, declares $150M cash dividend
Weibo (NASDAQ:WB) announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, demonstrating the platform's enduring position as China’s leading social media hub for real-time content.
Economy
Chalmers rejects recession fears despite latest rate hike
Treasurer Jim Chalmers has moved to de-escalate concerns of a looming economic contraction, pushing back against interpretations of RBA Governor Michele Bullock’s recent warnings.
Economy
Aussies defy cost pressures with record $83B spend
Australian consumers defy cost-of-living pressures with a record $83 billion online spend in 2025
Corazon Mining secures gold expansion at Plutonic Marymia
Corazon Mining (ASX:CZN) announced a major strategic expansion of its gold exploration portfolio in Western Australia.
Technology
Micron hits record $23.9B revenue as AI-driven memory demand triggers 30% dividend hike
Micron Technology (NASDAQ:MU) reported record-breaking financial results for its fiscal second quarter ended February 26, 2026, as the company continues to capitalize on the unprecedented demand for memory and storage solutions sparked by artificial intelligence.
Protagonist Therapeutics shares surge as FDA approves J&J-partnered psoriasis drug
Protagonist Therapeutics (NASDAQ:PTGX) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 and older weighing at least 40 kg.
Health
Cingulate targets May FDA decision for ADHD lead asset as capital runway extends
Cingulate (NASDAQ:CING) announced its fourth-quarter and full-year 2025 financial results alongside several critical regulatory milestones on March 18, 2026.
Retail
Macy’s beats Q4 estimates as Bloomingdale’s sales surge
Macy’s (NYSE:M) reported fourth-quarter 2025 financial results that cleared the high end of its previous guidance, driven by robust luxury demand and an accelerating turnaround within its core department store fleet.